# Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis

> **NCT05567068** · PHASE2 · COMPLETED · sponsor: **Tanta University** · enrollment: 54 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Atorvastatin 80mg
- **DRUG:** Mesalamine

## Key facts

- **NCT ID:** NCT05567068
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05567068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05567068, "Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05567068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*